<DOC>
	<DOCNO>NCT00369382</DOCNO>
	<brief_summary>The primary purpose study determine whether convert calcineurin inhibitor ( CNI ) therapy sirolimus therapy effective continue calcineurin inhibitor therapy respect renal function cardiac transplant recipient mild moderate renal dysfunction .</brief_summary>
	<brief_title>Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Cardiac transplant recipient age 18 year old receive cyclosporine tacrolimus since time transplant . 12 month cardiac transplantation le 96 month posttransplantation . Multipleorgan transplant recipient ( heartlung , heartkidney , heart kidney transplant recipient ) . Prior current use sirolimus everolimus unless administration part `` CNI holiday '' last 10 day . History acute rejection within last 3 month , malignancy within last 5 year ( except adequately treat basal cell squamous cell carcinoma skin ) , human immunodeficiency virus ( HIV ) patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Heart Transplant</keyword>
	<keyword>Kidney Failure</keyword>
</DOC>